# UBS AG: Form 20-F for the period ended Dec 31, 2023

- Company: [UBS AG](/companies/amub.md) (CIK 1114446)
- Form: 20-F
- Filed: 2024-03-28
- Accepted by EDGAR: Mar 28, 2024, 11:10 ET
- Period: 2023-12-31
- Accession: 0001114446-24-001605
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1114446/000111444624001605/ubs-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114446/000111444624001605/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | $1.21bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | $3.31bn | ifrs-full:ProfitLoss |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | −$28.20bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2023-12-31 | $190.47bn | ifrs-full:CashAndCashEquivalents |
| Total assets | at 2023-12-31 | $1.16tn | ifrs-full:Assets |
| Total liabilities | at 2023-12-31 | $1.10tn | ifrs-full:Liabilities |
| Shareholders' equity | at 2023-12-31 | $55.23bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2023-12-31 | 3,858,408,466 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114446/000111444624001605/ubs-20231231.htm

Filed Mar 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001114446-24-001605. Last ingested by Listed: Nov 6, 2026, 17:22 ET. No prices; not investment advice.